The efficiency of treatment with SGLT-2 inhibitors in metabolic and renal function

Project titled “The efficiency of treatment with SGLT-2 inhibitors in metabolic and renal function”, led by Prof. Dr. Florian Toti.

The aim of this study is to evaluate if SGLT2 inhibitors do really improve the quality of life of the patients, increase the life expectancy and reduce the costs of hospitalizations due to the reduction of heart failure in albanian population. Artificial Intelligence processing (from the researcher’s group Sorbone University) of ECG data aims to highlight whether these medications have a positive or negative impact on ECG.